Photodynamic therapy for age-related macular degeneration in a clinical setting: visual results and angiographic patterns.

[1]  M. Blumenkranz,et al.  Clinicopathologic study after submacular removal of choroidal neovascular membranes treated with verteporfin ocular photodynamic therapy. , 2003, American journal of ophthalmology.

[2]  D. Weinberger,et al.  Angiographic and flow patterns of retinal choroidal anastomoses in age-related macular degeneration with occult choroidal neovascularization. , 2002, Ophthalmology.

[3]  T. Cox,et al.  Decreased visual acuity associated with cystoid macular edema in neovascular age-related macular degeneration. , 2002, Archives of ophthalmology.

[4]  U. Schmidt-Erfurth,et al.  Histopathological changes following photodynamic therapy in human eyes. , 2002, Archives of ophthalmology.

[5]  J. Jonas.  VERTEPORFIN THERAPY OF SUBFOVEAL CHOROIDAL NEOVASCULARIZATION IN AGE-RELATED MACULAR DEGENERATION: Meta-Analysis of 2-Year Safety Results in Three Randomized Clinical Trials: Treatment of Age-Related Macular Degeneration with Photodynamic Therapy and Verteporfin in Photodynamic Therapy Study Report , 2002, American journal of ophthalmology.

[6]  U. Schmidt-Erfurth,et al.  Photodynamic effects on choroidal neovascularization and physiological choroid. , 2002, Investigative ophthalmology & visual science.

[7]  W. Green,et al.  CLINICOPATHOLOGIC STUDIES OF AGE-RELATED MACULAR DEGENERATION WITH CLASSIC SUBFOVEAL CHOROIDAL NEOVASCULARIZATION TREATED WITH PHOTODYNAMIC THERAPY , 2001, Retina.

[8]  N. Bressler,et al.  Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. , 1999, Archives of ophthalmology.

[9]  L A Yannuzzi,et al.  Retinal choroidal anastomoses and occult choroidal neovascularization in age-related macular degeneration. , 2000, Ophthalmology.

[10]  Joan W. Miller,et al.  Effects of photodynamic therapy using verteporfin on experimental choroidal neovascularization and normal retina and choroid up to 7 weeks after treatment. , 1999, Investigative ophthalmology & visual science.

[11]  A. Adamis,et al.  Ocular neovascularization: an epidemiologic review. , 1998, Survey of ophthalmology.

[12]  P. Mitchell,et al.  Bilateral involvement by age related maculopathy lesions in a population , 1998, The British journal of ophthalmology.

[13]  R. Flower,et al.  DISPARITY BETWEEN FUNDUS CAMERA AND SCANNING LASER OPHTHALMOSCOPE INDOCYANINE GREEN IMAGING OF RETINAL PIGMENT EPITHELIUM DETACHMENTS , 1998, Retina.

[14]  Flower Rw,et al.  Disparity between fundus camera and scanning laser ophthalmoscope indocyanine green imaging of retinal pigment epithelium detachments. , 1998 .

[15]  M G Maguire,et al.  Occult choroidal neovascularization in age-related macular degeneration. A natural history study. , 1997, Archives of ophthalmology.

[16]  Joan W. Miller,et al.  Liposomal benzoporphyrin derivative verteporfin photodynamic therapy. Selective treatment of choroidal neovascularization in monkeys. , 1996, Ophthalmology.

[17]  G. Soubrane,et al.  Imaging of chorioretinal anastomoses in vascularized retinal pigment epithelium detachments. , 1995, Archives of ophthalmology.

[18]  N. Bressler,et al.  Loculated fluid. A previously undescribed fluorescein angiographic finding in choroidal neovascularization associated with macular degeneration. Macular Photocoagulation Study Reading Center. , 1991, Archives of ophthalmology.

[19]  G Soubrane,et al.  Occult subretinal new vessels in age-related macular degeneration. Natural History and early laser treatment. , 1990, Ophthalmology.

[20]  A. Bird,et al.  Senile disciform macular degeneration in the second eye. , 1977, The British journal of ophthalmology.

[21]  P. Kertes,et al.  Photodynamic Therapy of Subfoveal Choroidal Neovascularization with Verteporfin , 2004 .

[22]  S. Harding.  Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials¿TAP Report No. 5 , 2002 .

[23]  Neil M Bressler,et al.  Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2. , 2002, American journal of ophthalmology.

[24]  Flower Rw.  Expanded hypothesis on the mechanism of photodynamic therapy action on choroidal neovascularization. , 1999 .

[25]  T J Flotte,et al.  Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin. , 1995, Archives of ophthalmology.

[26]  Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group. , 1991, Archives of ophthalmology.

[27]  G. Coscas,et al.  [Macular degeneration related to age and cystoid macular edema. Apropos of 95 cases (100 eyes)]. , 1988, Journal francais d'ophtalmologie.